Breaking News

Plasticell, Progenitor Labs Join SBC Campus

Will utilize open innovation to discover regenerative medicines

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Plasticell Ltd. and Progenitor Labs have joined Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation bioscience campus. Progenitor Labs is a drug discovery spin-off from Plasticell and recently received £4m in funding from SR One, the corporate venture arm of GlaxoSmithKline. SBC focuses on cell therapy and regenerative medicine innovation activities. Plasticell specializes in the differentiation of stem cells to obtain cell types for a range of biomedical applications using C...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters